Skip to main content

Advertisement

Table 2 HBVa, HCVb and HTLVc 1&2 seroprevalence by demographic and behavioral characteristics among MSMd and associated factors in Ouagadougou

From: Hepatitis B, C, and D virus and human T-cell leukemia virus types 1 and 2 infections and correlates among men who have sex with men in Ouagadougou, Burkina Faso

Variables n HBV HCV HTLV 1&2
HBV positive RDSe-adjusted HBV Positive (95% CIf) HCV positive RDS-adjusted HCV Positive (95% CI) HTLV1&2 positive RDS-adjusted HTLV1&2 Positive (95% CI)
Current age (years)
 18–19 78 17.9 17.7 (10.7–27.8) 7.7 7.3 (3.2–15.5) 3.8 3.9 (1.3–11.5)
 20–24 196 19.9 19.6 (14.6–25.7) 13.3 13.3 (9.2–18.9) 4.1 4.1 (2.1–8.0)
 25–29 35 22.9 23.1 (12.0–40.0) 2.9 02.9 (0.4–18.0) 0.0
  > =30 20 35.0 35.9 (18.0–58.9) 15.6 16.4 (5.4–40.3) 10.0 10.9 (2.7–34.8)
Total 329 20.7 20.4 (16.4–25.1) 10.9 11.0 (8.0–14.8) 4.0 4.0 (2.3–6.8)
Country of birth
 Burkina Faso 272 21.0 20.7 (16.3–25.9) 9.9 09.9 (6.9–14.1) 4.0 4.1 (2.3–7.3)
 Other countries 57 19.3 18.8 (10.7–31.1) 15.8 16.0 (8.5–28.1) 3.5 3.6 (0.9–13.2)
Childhood environment
 Urban 288 20.3 20.0 (15.8–25.0) 10.8 10.8 (7.6–14.9) 4.2 4.2 (2.4–7.3)
 Rural 27 33.3 32.3 (17.5–51.7) 14.8 15.1 (5.7–34.0) 3.7 3.8 (0.5–22.6)
Highest educational level
 None or primary 25 24.0 24.4 (11.4–44.9) 4.0 4.1 (0.6–24.1) 4.0 4.1 (0.6–24.1)
 Secondary 239 16.5 16.2 (12.0–21.4) 11.7 11.7 (8.1–16.4) 4.2 4.2 (2.3–7.7)
 University 65 34.8 34.5 (23.9–46.7) 10.8 11.0 (5.3–21.4) 3.1 3.1 (0.8–11.8)
Occupation
 Student/pupil 236 18.1 17.9 (13.5–23.3) 12.3 12.2 (8.6–17.1) 3.8 3.8 (2.0–7.3)
 Employed 72 28.8 28.4 (19.2–39.9) 5.6 5.7 (2.2–14.3) 2.8 2.9 (0.7–10.8)
 Unemployed 21 22.7 21.2 (8.9–42.6) 14.3 14.3 (4.7–36.3) 9.5 9.5 (2.4–31.3)
Marital status (with a woman)
 Single 310 19.4 19.1 (15.1–23.9) 11.0 10.9 (7.9–15.0) 3.9 3.9 (2.2–6.8)
 Otherg 18 42.1 42.7 (22.8–65.3) 10.5 11.3 (2.8–35.7) 5.3 5.6 (0.8–31.2
Number of biological children
 0 305 20.8 20.5 (16.3–25.3) 10.5 10.5 (7.5–14.4) 3.9 4.0 (2.3–6.9)
  > =1 24 20.8 20.1 (8.4–40.8) 16.7 17.6 (6.8–38.6) 4.2 4.4 (0.6–25.6)
Sexual orientation
 Gay/homosexual 236 20.3 20.1 (15.5–25.7) 10.2 10.3 (7.0–14.9) 3.0 3.0 (1.4–6.2)
 Bisexual 21 31.8 30.5 (15.0–52.1) 19.0 19.0 (7.3–41.3) 4.8 4.8 (0.7–27.4)
 Heterosexual 72 19.2 18.4 (11.1–29.0) 11.1 10.8 (5.4–20.3) 6.9 7.1 (3.0–16.0)
Anal sex position
 Receptive 19 26.3 26.9 (11.6–50.7) 10.5 10.8 (2.7–34.5 0.0 0.0
 Insertive 310 20.5 20.1 (16.0–24.9) 11.0 11.0 (7.9–15.0) 5.0 5.0 (2.8–8.9)
Tested for STIh in the last 12 months
 No 241 18.7 18.5 (14.1–24.0) 12.0 12.0 (8.4–16.8) 3.8 3.4 (1.7–6.6)
 Yes 85 27.6 26.8 (18.5–37.1) 8.2 8.4 (4.0–16.6) 4.7 4.8 (1.8–12.2)
Past 12 month STI symptoms
 No 311 19.6 19.4 (15.4–24.3) 11.3 11.3 (8.2–15.3) 2.9 2.9 (1.5–5.6)
 Yes 18 38.9 37.4 (18.6–61.0) 5.6 5.7 (0.8–31.4) 22.2 22.8 (8.8–47.4)
Vaccinated against HBV
 No 264 22.7 22.4 (17.8–27.9) 10.2 10.2 (7.1–14.5) 3.0 3.1 (1.5–6.0)
 Yes 51 15.7 15.8 (8.1–28.6) 13.7 13.8 (6.7–26.4) 5.9 5.9 (1.9–16.9)
 Don’t know 14 0.0 14.3 14.3 (3.6–42.9) 14.3 14.3 (3.6–42.9)
At least 2 sexual partners in the last 12 months
 Only males 268 17.9 17.7 (13.6–22.8) 10.8 10.9 (7.7–15.3) 4.5 4.5 (2.6–7.8)
 Males and females 60 33.3 33.1 (22.3–46.0) 11.7 11.4 (5.4–22.2) 0.0 0
Type of sexual partners in the last 12 months
 Only males 201 19.9 19.8 (14.8–26.0) 12.9 12.9 (8.9–18.4) 2.0 2.0 (0.8–5.3)
 Males and females 127 22.0 21.5 (15.2–29.5) 7.9 7.9 (4.3–14.1) 6.3 6.3 (3.2–12.2)
Ever experienced condom tearing during anal sex
 No 218 17.4 17.4 (12.9–23.0) 11.9 12.0 (8.3–17.1) 4.6 4.6 (2.5–8.4)
 Yes 106 28.7 27.8 (20.1–37.0) 9.4 9.2 (5.0–16.4) 2.8 2.9 (0.9–8.6)
Condom use at last anal sex with a main male partner
 No 54 29.6 29.9 (19.1–43.4) 5.6 5.6 (1.8–16.1) 9.3 9.3 (3.9–20.6)
 Yes 240 17.1 16.6 (12.4–21.9) 11.3 11.2 (7.8–15.9) 2.1 2.1 (0.9–5.0)
Condom use at last anal sex with a casual male partner
 No 34 17.6 17.9 (8.2–34.6) 11.8 11.9 (4.5–27.9) 8.8 8.9 (2.9–24.4)
 Yes 224 19.6 19.2 (14.5–24.9) 10.3 10.4 (7.0–15.2) 3.6 3.6 (1.8–7.1)
HIVi status
 Positive 10 40.0 40.0 (15.7–70.4) 10.0 11.0 (8.0–14.9) 0 0.0
 Negative 319 20.1 20.1 (16.0–24.8) 11.0 10.0 (1.4–47.0) 4.1 4.1 (2.4–6.9)
Ever injected drugs
 No 323 20.7 20.5 (16.4–25.3) 11.0 11.2 (8.1–15.1) 3.7 3.8 (2.1–6.5)
 Yes 6 16.7 16.7 (2.3–63.4) 0.0 16.7 16.7 (2.3–63.4)
  1. aHBV Hepatitis B virus
  2. bHCV Hepatitis C virus
  3. cHTLV Human T-cell leukemia virus
  4. dMSM Men who have sex with men
  5. eRDS Respondent driven sampling
  6. fCI Confidence interval
  7. gMarried or cohabiting, divorced, separated
  8. hSTI Sexually transmitted infection
  9. iHIV Human immunodeficiency virus